Free Trial

Novavax (NVAX) SEC Filings & 10K Form

Novavax logo
$7.58 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$7.56 -0.03 (-0.33%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Novavax SEC Filings

DateFilerForm TypeView
08/27/2025
3:38 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2025
3:40 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2025
6:48 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2025
7:04 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2025
6:47 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/24/2025
5:37 PM
DOUGLAS RICHARD (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:39 PM
King Rachel K. (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:40 PM
MOTT DAVID M (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:40 PM
Novavax (Issuer)
Rodgers Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:35 PM
MCGLYNN MARGARET G (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:36 PM
Alton Gregg H (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:03 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
8:39 PM
MOTT DAVID M (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
8:40 PM
Novavax (Issuer)
Rodgers Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
8:41 PM
King Rachel K. (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
8:36 PM
DOUGLAS RICHARD (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
6:01 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025
6:34 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:26 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:59 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2025
8:25 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
5:01 AM
Novavax (Filer)
Form DEFA14A
04/29/2025
7:51 AM
Novavax (Filer)
Form DEF 14A
04/29/2025
7:54 AM
Novavax (Filer)
Form ARS
04/29/2025
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
7:06 AM
Newton Charles W. (Reporting)
Novavax (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/29/2025
7:08 AM
Newton Charles W. (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2025
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2025
3:19 PM
Novavax (Subject)
YOUNG JAMES F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2025
1:52 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
7:03 PM
Novavax (Issuer)
Shiver John W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
7:04 PM
Novavax (Issuer)
Shiver John W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:33 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:34 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:30 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
4:03 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:04 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:07 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:39 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:42 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:43 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel

Watch the National Emergency broadcast here
03/04/2025
5:46 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:01 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
7:05 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:41 AM
Novavax (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2025
6:04 PM
MCGLYNN MARGARET G (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:06 PM
Alton Gregg H (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Novavax (Subject)
Form SCHEDULE 13G/A
01/27/2025
5:19 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:50 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
4:41 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:52 PM
Novavax (Issuer)
Rodgers Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:44 PM
Novavax (Issuer)
YOUNG JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:47 PM
King Rachel K. (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:02 PM
Novavax (Subject)
YOUNG JAMES F (Reporting)
Form 144/A
12/30/2024
4:27 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
9:31 AM
Novavax (Subject)
YOUNG JAMES F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2024
4:24 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:24 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
11:13 AM
King Rachel K. (Reporting)
Novavax (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2024
5:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:05 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
3:08 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:21 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:01 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:19 PM
Novavax (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/16/2024
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
3:08 PM
Dubovsky Filip (Reporting)
Novavax (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NVAX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners